Naomi Nakayama

No ORCID on file · 5 papers in corpus · active 2012-2025

Study types

  • article 3
  • other 2

Condition tags

  • endometriosis 3
  • adenomyosis 2
  • dysmenorrhea 1
article 2025
International journal of molecular sciences ·doi:10.3390/ijms26104938

NAC1, a transcription regulator protein associated with cancer, is highly expressed in several tumor types, including ovarian cancer. However, it remains unclear how NAC1 is involved in carcinogenesis. Our previous studies demonstrated that…

other 2025
International journal of molecular sciences ·doi:10.3390/ijms26199379

Nucleus accumbens-associated protein 1 (NAC1), a cancer-related transcriptional regulator, is overexpressed in several malignancies, including ovarian cancer. However, its role in ovarian carcinogenesis remains unclear. We aimed to investig…

article 2013
Masui. The Japanese journal of anesthesiology

We report anesthetic management of a 38-year-old woman with pulmonary thromboembolism for total hysterectomy. She had been taking oral contraceptives for adenomyosis of the uterus. She had thrombi in the arteries from pulmonary trunk to bil…

article 2013
Journal of Obstetrics and Gynaecology Research ·doi:10.1111/jog.12163

AIM: We aimed to evaluate the efficacy of microwave endometrial ablation at a frequency of 2.45 GHz in women with menorrhagia. This method has been attracting attention as an alternative to hysterectomy in the treatment of functional and or…

other 2012
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc ·doi:10.1038/modpathol.2011.161

Recently, the ARID1A gene has been identified as a novel tumor suppressor in ovarian clear cell carcinoma. The prognostic significance of the loss of ARID1A expression is not known. The current study was designed to evaluate whether ARID1A …